Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Recent investment activity
KANDO id: 29979
Corporate information
Founders
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Company type
American investment firm focused on making public and private investments in the healthcare and biotechnology industries.Overview
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Funds managed
Fund | Type | Vintage | Currency | Committed capital | IRR | x |
---|---|---|---|---|---|---|
OrbiMed Private Investments VII | 2017 | |||||
OrbiMed Private Investments VI LP | 2015 | |||||
Orbimed Global Healthcare Associates Fund LP | Hedge fund | 2014 | ||||
OrbiMed Global Healthcare Fund LP | Hedge fund | 2014 | ||||
OrbiMed Global Healthcare Fund Ltd | Hedge fund | 2013 | ||||
OrbiMed Healthcare Investments Fund (Offshore) LP | 2013 | USD | 29,575,000 | |||
OrbiMed Private Investments V LP | 2013 | |||||
OrbiMed Private Investments IV LP | Venture | 2009 | 45.20 % | 2.78 x | ||
OrbiMed Private Investments III LP | Venture | 2006 | 21.30 % | 2.54 x | ||
OrbiMed Partners II LP | Hedge fund | 1998 | ||||
OrbiMed Partners LP | Hedge fund | 1993 | ||||
OrbiMed Healthcare Investments Trust | ||||||
OrbiMed Royalty Opportunities II LP |
Funding rounds
Investment preferences
Investment focus themes
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 114Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
Insulet Corp | N/A | |||||
Vivus Inc | N/A | |||||
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | N/A | ||||
Caliper Life Sciences Inc | N/A | |||||
XenoPort Inc | N/A Initial investment | |||||
ARYx Therapeutics Inc | N/A Initial investment | |||||
Anthera Pharmaceuticals Inc | N/A | |||||
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series B | ||||
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series D | ||||
Amnis Corp | A biotechnology company developing high throughput laboratory automation tools that use a novel molecule detection technology. | Series C | ||||
Avalon Pharmaceuticals Inc | Biopharmaceutical company focused on the discovery and development of small molecule therapeutics for the treatment of cancer. | N/A | ||||
EUSA Pharma Inc | Trans-Atlantic specialty pharmaceutical company which focuses on oncology and critical care | Venture | ||||
Orphan Medical Inc | N/A | |||||
Amarin Pharmaceuticals Inc | N/A | |||||
NxStage Medical Inc | Hemofiltration for kidney failure | N/A | ||||
Sientra Inc | Medical device company | Series C | ||||
Vessix Vascular Inc | Developing novel radiofrequency balloon catheter technology. | N/A | ||||
ViewRay Inc [] | A medical device company, develops advanced radiation therapy solutions for the treatment of cancer. | N/A | ||||
RDD Pharma Ltd | Drug-device company that developed an intra-anal drug delivery device. | N/A | ||||
Adolor Corp | N/A | |||||
Connetics Corp | N/A | |||||
Agensys Inc | Series D | |||||
Cell Therapeutics Inc | Biotherapeutics for cancer treatment. | N/A | ||||
superDimension Ltd | Diagnose and potentially treat lung disease and lung cancer. | N/A | ||||
Affimed Therapeutics AG | Antibody therapeutics for cancer and inflammatory diseases. | N/A |
Pagination
Team
Employee | Position | |||
---|---|---|---|---|
Nissim Darvish | ||||
W. Carter Neild | [email protected] | |||
William Sawyer | ||||
Trevor Polischuk |